Oxford Technology Management et al. invest £2.5m in Microvisk

Microvisk will use the new capital to finalise product development for its SmartStrip technology, and start the testing necessary to secure regulatory approval in Europe and the US. The company is on track to launch its system onto the market in 2011.

The group of institutional investors had already backed Microvisk in January 2010 with a £2m investment.

Based in Wales, and originally a spin-out company of the Science and Technology Facilities Council, Microvisk became an independent business in 2004. Its SmartStrip technology is used to assess the clotting ability of patients using the Warfarin drug.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Early-stage
• Healthcare
• Midven